<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD01320000_2</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P06737</UniProt_ID>
  <Seq_Length>847</Seq_Length>
  <Molecule_Weight>97149</Molecule_Weight>
  <KEGG_ID>hsa:5836</KEGG_ID>
  <Orthology_ID>K00688</Orthology_ID>
  <Function_Summary>Phosphorylase is an important allosteric enzyme in carbohydrate metabolism. Enzymes from different sources differ in their regulatory mechanisms and in their natural substrates. However, all known phosphorylases share catalytic and structural properties.</Function_Summary>
  <Catalytic_Mechanism>(1,4-alpha-D-glucosyl)(n) + phosphate = (1,4-alpha-D-glucosyl)(n-1) + alpha-D-glucose 1-phosphate.</Catalytic_Mechanism>
  <Pfam_ID>PF00343:Phosphorylase</Pfam_ID>
  <Allosteric_Activator_Count>2</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>135</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>3</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Glycogen phosphorylase, liver form</Alias>
      <Alias>HLGP</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose.</Detail>
      <Keyword>Nucleotide binding</Keyword>
      <Ontology_ID>GO:0000166</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with an identical protein to form a homodimer.</Detail>
      <Keyword>Protein homodimerization activity</Keyword>
      <Ontology_ID>GO:0042803</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of a biochemical reaction at physiological temperatures. In biologically catalyzed reactions, the reactants are known as substrates, and the catalysts are naturally occurring macromolecular substances known as enzymes. Enzymes possess specific binding sites for substrates, and are usually composed wholly or largely of protein, but RNA that has catalytic activity (ribozyme) is often also regarded as enzymatic.</Detail>
      <Keyword>Catalytic activity</Keyword>
      <Ontology_ID>GO:0003824</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2.</Detail>
      <Keyword>Transferase activity</Keyword>
      <Ontology_ID>GO:0016740</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a drug, any naturally occurring or synthetic substance, other than a nutrient, that, when administered or applied to an organism, affects the structure or functioning of the organism; in particular, any such substance used in the diagnosis, prevention, or treatment of disease.</Detail>
      <Keyword>Drug binding</Keyword>
      <Ontology_ID>GO:0008144</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: glycogen + phosphate = maltodextrin + alpha-D-glucose 1-phosphate.</Detail>
      <Keyword>Glycogen phosphorylase activity</Keyword>
      <Ontology_ID>GO:0008184</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with pyridoxal 5' phosphate, 3-hydroxy-5-(hydroxymethyl)-2-methyl4-pyridine carboxaldehyde 5' phosphate, the biologically active form of vitamin B6.</Detail>
      <Keyword>Pyridoxal phosphate binding</Keyword>
      <Ontology_ID>GO:0030170</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.</Detail>
      <Keyword>ATP binding</Keyword>
      <Ontology_ID>GO:0005524</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with the D- or L-enantiomer of glucose.</Detail>
      <Keyword>Glucose binding</Keyword>
      <Ontology_ID>GO:0005536</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a purine base, an organic nitrogenous base with a purine skeleton.</Detail>
      <Keyword>Purine base binding</Keyword>
      <Ontology_ID>GO:0002060</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the transfer of a glycosyl group from one compound (donor) to another (acceptor).</Detail>
      <Keyword>Transferase activity, transferring glycosyl groups</Keyword>
      <Ontology_ID>GO:0016757</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with AMP, adenosine monophosphate.</Detail>
      <Keyword>AMP binding</Keyword>
      <Ontology_ID>GO:0016208</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with bile acids, any of a group of steroid carboxylic acids occurring in bile.</Detail>
      <Keyword>Bile acid binding</Keyword>
      <Ontology_ID>GO:0032052</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>698</Position>
      <Original>Val</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>715</Position>
      <Original>Arg</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>806</Position>
      <Original>Ile</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>222</Position>
      <Original>Val</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>339</Position>
      <Original>Asn</Original>
      <Variation>Ser</Variation>
    </Muntion>
    <Muntion>
      <Position>377</Position>
      <Original>Asn</Original>
      <Variation>Lys</Variation>
    </Muntion>
    <Muntion>
      <Position>425</Position>
      <Original>Arg</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>231</Position>
      <Original>Val</Original>
      <Variation>Glu</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The chemical reactions and pathways involving glucose, the aldohexose gluco-hexose. D-glucose is dextrorotatory and is sometimes known as dextrose; it is an important source of energy for living organisms and is found free as well as combined in homo- and hetero-oligosaccharides and polysaccharides.</Detail>
      <Keyword>Glucose metabolic process</Keyword>
      <Ontology_ID>GO:0006006</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways resulting in the breakdown of glycogen, a polydisperse, highly branched glucan composed of chains of D-glucose residues.</Detail>
      <Keyword>Glycogen catabolic process</Keyword>
      <Ontology_ID>GO:0005980</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process involved in the maintenance of an internal steady state of glucose within an organism or cell.</Detail>
      <Keyword>Glucose homeostasis</Keyword>
      <Ontology_ID>GO:0042593</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways involving carbohydrates, any of a group of organic compounds based of the general formula Cx(H2O)y. Includes the formation of carbohydrate derivatives by the addition of a carbohydrate residue to another molecule.</Detail>
      <Keyword>Carbohydrate metabolic process</Keyword>
      <Ontology_ID>GO:0005975</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways involving glycogen, a polydisperse, highly branched glucan composed of chains of D-glucose residues in alpha(1-&gt;4) glycosidic linkage, joined together by alpha(1-&gt;6) glycosidic linkages.</Detail>
      <Keyword>Glycogen metabolic process</Keyword>
      <Ontology_ID>GO:0005977</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>76</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>75</Position>
      <PTM_Type>Phosphotyrosine</PTM_Type>
    </PTM>
    <PTM>
      <Position>2</Position>
      <PTM_Type>N-acetylalanine</PTM_Type>
    </PTM>
    <PTM>
      <Position>15</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
    <PTM>
      <Position>681</Position>
      <PTM_Type>N6-(pyridoxal phosphate)lysine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MAKPLTDQEKRRQISIRGIVGVENVAELKKSFNRHLHFTLVKDRNVATTRDYYFALAHTVRDHLVGRWIRTQQHYYDKCPKRVYYLSLEFYMGRTLQNTMINLGLQNACDEAIYQLGLDIEELEEIEEDAGLGNGGLGRLAACFLDSMATLGLAAYGYGIRYEYGIFNQKIRDGWQVEEADDWLRYGNPWEKSRPEFMLPVHFYGKVEHTNTGTKWIDTQVVLALPYDTPVPGYMNNTVNTMRLWSARAPNDFNLRDFNVGDYIQAVLDRNLAENISRVLYPNDNFFEGKELRLKQEYFVVAATLQDIIRRFKASKFGSTRGAGTVFDAFPDQVAIQLNDTHPALAIPELMRIFVDIEKLPWSKAWELTQKTFAYTNHTVLPEALERWPVDLVEKLLPRHLEIIYEINQKHLDRIVALFPKDVDRLRRMSLIEEEGSKRINMAHLCIVGSHAVNGVAKIHSDIVKTKVFKDFSELEPDKFQNKTNGITPRRWLLLCNPGLAELIAEKIGEDYVKDLSQLTKLHSFLGDDVFLRELAKVKQENKLKFSQFLETEYKVKINPSSMFDVQVKRIHEYKRQLLNCLHVITMYNRIKKDPKKLFVPRTVIIGGKAAPGYHMAKMIIKLITSVADVVNNDPMVGSKLKVIFLENYRVSLAEKVIPATDLSEQISTAGTEASGTGNMKFMLNGALTIGTMDGANVEMAEEAGEENLFIFGMRIDDVAALDKKGYEAKEYYEALPELKLVIDQIDNGFFSPKQPDLFKDIINMLFYHDRFKVFADYEAYVKCQDKVSQLYMNPKAWNTMVLKNIAASGKFSSDRTIKEYAQNIWNVEPSDLKISLSNESNKVNGN</Protein_Seq>
    <DNA_Seq>GTTGAAAGCTCCTGGCGCGGCGGGGCGGACTCCACCCCTGCCCGGCAGCCCAGCGCCTCCGGCCGCACTTCCAGCTCTCTGCGCAGCCCGCCGCGCAGCCCGCCGCCCCAGCCATGGGCGAACCGCTGACAGACCAGGAGAAGCGGCGGCAGATCAGCATCCGCGGCATCGTGGGCGTGGAGAACGTGGCAGAGCTGAAGAAGAGTTTCAACCGGCACCTGCACTTCACGCTGGTCAAGGACCGCAACGTGGCCACCACCCGCGACTACTACTTCGCGCTGGCGCACACGGTGCGGGACCACCTGGTGGGGCGCTGGATCCGCACGCAGCAGCACTACTACGACAAGTGCCCCAAGAGGGAATATTACCTCTCTCTGGAATTTTACATGGGCCGAACATTACAGAACACCATGATCAACCTCGGTCTGCAAAATGCCTGTGATGAGGCCATTTACCAGCTTGGATTGGATATAGAAGAGTTAGAAGAAATTGAAGAAGATGCTGGACTTGGCAATGGTGGTCTTGGGAGACTTGCTGCCTGCTTCTTGGATTCCATGGCAACCCTGGGACTTGCAGCCTATGGATACGGCATTCGGTATGAATATGGGATTTTCAATCAGAAGATCCGAGATGGATGGCAGGTAGAAGAAGCAGATGATTGGCTCAGATATGGAAACCCTTGGGAGAAGTCCCGCCCAGAATTCATGCTGCCTGTGCACTTCTATGGAAAAGTAGAACACACCAACACCGGGACCAAGTGGATTGACACTCAAGTGGTCCTGGCTCTGCCATATGACACCCCCGAGCCCGGCTACATGAATAACACTGTCAACACCATGCGCCTCTGGTCTGCTCGGGCACCAAATGACTTTAACCTCAGAGACTTTAATGTTGGAGACTACATTCAGGCTGTGCTGGACCGAAACCTGGCCGAGAACATCTCCCGGGTCCTCTATCCCAATGACAATTTTTTTGAAGGGAAGGAGCTAAGATTGAAGCAGGAATACTTTGTGGTGGCTGCAACCTTGCAAGATATCATCCGCCGTTTCAAAGCCTCCAAGTTTGGCTCCACCCGTGGTCAAGGAACTGTGTTTGATGCCTTCCCGGATCAGGTGGCCATCCAGCTGAATGATACTCACCCTCGCATCGCGATCCCTGAGCTGATGAGGATTTTTGTGGATATTGAAAAACTGCCCTGGTCCAAGGCATGGGAGCTCAACCAGAAGACCTTCGCCTACACCAACCACACAGTGCTCCCGGAAGCCCTGGAGCGCTGGCCCGTGGACCTGGTGGAGAAGCTGCTCCCTCGACATTTGGAAATCATTTATGAGATAAATCAGAAGCATTTAGATAGAATTGTGGCCTTGTTTCCTAAAGATGTGGACCCTCTGAGAAGGATGTCTCTGATAGAAGAGGAAGGAAGCAAAAGGATCAACATGGCCCATCTCTGCATTGTCGGTTCCCATGCTGTGAATGGCGTGGCTAAAATCCACTCAGACATCGTGAAGACTAAAGTATTCAAGGACTTCAGTGAGCTAGAACCTGACAAGTTTCAGAATAAAACCAATGGGATCACTCCAAGGCGCTGGCTCCTACTCTGCAACCCAGGACTTGCAGAGCTCATAGCAGAGAAAATTGGAGAAGACTATGTGAAAGACCTGAGCCAGCTGACGAAGCTCCACAGCTTCCTGGGTGATGATGTCTTCCTCCGGGAACTCGCCAAGGTGAAGCAGGAGAATAAGCTGAAGTTTTCTCAGTTCCTGGAGACGGAGTACAAAGTGAAGATCAACCCATCCTCCATGTTTGATGTCCAGGTGAAGAGGATACATGAGTACAAGCGACAGCTCTTGAACTGTCTGCATGTGATCACGATGTACAACCGCATTAAGAAAGACCCTAAGAAGTTATTCGTGCCAAGGACAGTTATCATTGGTGGTAAAGCTGCCCCAGGATATCACATGGCCAAAATGATCATAAAGCTGATCACTTCAGTGGCAGATGTGGTGAACAATGACCCTATGGTTGGAAGCAAGTTGAAAGTCATCTTCTTGGAGAACTACAGAGTATCTCTTGCTGAAAAAGTCATTCCAGCCACAGATCTGTCAGAGCAGATTTCCACTGCAGGCACCGAAGCCTCGGGGACAGGCAATATGAAGTTCATGCTAAATGGGGCCCTAACTATCGGGACCATGGATGGGGCCAATGTGGAAATGGCAGAAGAAGCTGGGGAAGAGAACCTGTTCATCTTTGGCATGAGCATAGATGATGTGGCTGCTTTGGACAAGAAAGGGTACGAGGCAAAAGAATACTATGAGGCACTTCCAGAGCTGAAGCTGGTCATTGATCAAATTGACAATGGCTTTTTTTCTCCCAAGCAGCCTGACCTCTTCAAAGATATCATCAACATGCTATTTTATCATGACAGGTTTAAAGTCTTTGCAGACTACGAAGCCTATGTCAAGTGTCAAGATAAAGTGAGTCAGCTGTACATGAATCCAAAGGCCTGGAACACAATGGTACTCAAAAACATAGCTGCCTCGGGGAAATTCTCCAGTGACCGAACAATTAAAGAATATGCCCAAAACATCTGGAACGTGGAACCTTCAGATCTAAAGATTTCTCTATCCAATGAATCTAACAAAGTCAATGGAAATTGAACTCTACAATGTCTCTAGAAAACATAGCTTCTTACTGAACTTGAACATTTTTACAACATTCACTGGTTTTTGTTTTGTTAGCTAATAATCTATAATAGTTGAGTATCTCTGGGAATGGGGAGGGAAATTATATGTAATAGAGCTTAAAAATAAAGTGTCAATTTCCAAGGA</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Liver</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <Gene>
    <Gene_Name>PYGL</Gene_Name>
    <Gene_ID>5836</Gene_ID>
    <Genbank_ACCN>NM_001163940</Genbank_ACCN>
    <Protein_ACCN>NP_001157412</Protein_ACCN>
    <HGNC_ID>9725</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/5836</Gene_URL>
    <UCSC_ID>uc001wyu.3</UCSC_ID>
    <EMBL_ID>ENSG00000100504</EMBL_ID>
  </Gene>
  <Disease_List>
    <Disease>
      <Disease_Name>Hypoglycemia</Disease_Name>
      <Disease_Detail>Hypoglycemia</Disease_Detail>
      <Disease_DB>HYP056</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/hypoglycemia?search=PYGL#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Glycogen Storage Disease Vi</Disease_Name>
      <Disease_Detail>Glycogen Storage Disease</Disease_Detail>
      <Disease_DB>GLY005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/glycogen_storage_disease_vi?search=PYGL#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Glycogen Storage Disease</Disease_Name>
      <Disease_Detail>Glycogen Storage Disease</Disease_Detail>
      <Disease_DB>GLY013</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/glycogen_storage_disease?search=PYGL#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Human liver glycogen phosphorylase a complexed with caffeine, N-Acetyl-beta-D-glucopyranosylamine, and CP-403700</PDB_Title>
      <PDB_ID>1L5Q</PDB_ID>
      <Resolution>2.25</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1L5Q</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01320120;ASD01320044</ASD_Ligand>
      <Ligand_Name>[5-CHLORO-1H-INDOL-2-CARBONYL-PHENYLALANINYL]- AZETIDINE-3-CARBOXYLIC ACID$CAFFEINE $1-N-ACETYL-BETA-D-GLUCOSAMINE $PYRIDOXAL-5'-PHOSPHATE</Ligand_Name>
      <PubMed_Title>Structure-activity analysis of the purine binding  site of human liver glycogen phosphorylase.</PubMed_Title>
      <Author>Ekstrom JL, et al.</Author>
      <Journal>Chem Biol.2002 Aug;9(8):915-24.</Journal>
      <PubMed_ID>12204691</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN LIVER GLYCOGEN PHOSPHORYLASE A COMPLEXED WITH GLCNAC AND CP-403,700</PDB_Title>
      <PDB_ID>1EXV</PDB_ID>
      <Resolution>2.4</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1EXV</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01320120;ASD01320124</ASD_Ligand>
      <Ligand_Name>[5-CHLORO-1H-INDOL-2-CARBONYL-PHENYLALANINYL]- AZETIDINE-3-CARBOXYLIC ACID $(4S)-2-METHYL-2,4-PENTANEDIOL $1-N-ACETYL-BETA-D-GLUCOSAMINE $PYRIDOXAL-5'-PHOSPHATE</Ligand_Name>
      <PubMed_Title>Human liver glycogen phosphorylase inhibitors bind at a new allosteric site.</PubMed_Title>
      <Author>Rath VL, et al.</Author>
      <Journal>Chem Biol.2000 Sep;7(9):677-82.</Journal>
      <PubMed_ID>10980448</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN LIVER GLYCOGEN PHOSPHORYLASE A COMPLEXED WITH AMP</PDB_Title>
      <PDB_ID>1FA9</PDB_ID>
      <Resolution>2.4</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1FA9</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD00030001</ASD_Ligand>
      <Ligand_Name>ADENOSINE MONOPHOSPHATE $ALPHA-D-GLUCOSE $PYRIDOXAL-5'-PHOSPHATE</Ligand_Name>
      <PubMed_Title>Activation of human liver glycogen phosphorylase by alteration of the secondary structure and packing of the catalytic core.</PubMed_Title>
      <Author>Rath VL, et al.</Author>
      <Journal>Mol Cell.2000 Jul;6(1):139-48.</Journal>
      <PubMed_ID>10949035</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human liver glycogen phosphorylase a complexed with riboflavin, N-Acetyl-beta-D-Glucopyranosylamine and CP-403,700</PDB_Title>
      <PDB_ID>1L5R</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1L5R</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01320120;ASD01320121</ASD_Ligand>
      <Ligand_Name>[5-CHLORO-1H-INDOL-2-CARBONYL-PHENYLALANINYL]- AZETIDINE-3-CARBOXYLIC ACID $(4R)-2-METHYLPENTANE-2,4-DIOL $1-N-ACETYL-BETA-D-GLUCOSAMINE $PYRIDOXAL-5'-PHOSPHATE $RIBOFLAVIN</Ligand_Name>
      <PubMed_Title>Structure-activity analysis of the purine binding  site of human liver glycogen phosphorylase.</PubMed_Title>
      <Author>Ekstrom JL, et al.</Author>
      <Journal>Chem Biol.2002 Aug;9(8):915-24.</Journal>
      <PubMed_ID>12204691</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human liver glycogen phosphorylase b complexed with caffeine, N-acetyl-beta-D-glucopyranosylamine, and CP-403,700</PDB_Title>
      <PDB_ID>1L7X</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1L7X</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01320120;ASD01320044</ASD_Ligand>
      <Ligand_Name>[5-CHLORO-1H-INDOL-2-CARBONYL-PHENYLALANINYL]- AZETIDINE-3-CARBOXYLIC ACID $CAFFEINE $(4R)-2-METHYLPENTANE-2,4-DIOL $1-N-ACETYL-BETA-D-GLUCOSAMINE $PYRIDOXAL-5'-PHOSPHATE</Ligand_Name>
      <PubMed_Title>Structure-activity analysis of the purine binding  site of human liver glycogen phosphorylase.</PubMed_Title>
      <Author>Ekstrom JL, et al.</Author>
      <Journal>Chem Biol.2002 Aug;9(8):915-24.</Journal>
      <PubMed_ID>12204691</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN LIVER GLYCOGEN PHOSPHORYLASE A COMPLEXED WITH GLCNAC AND CP-526,423</PDB_Title>
      <PDB_ID>1EM6</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1EM6</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01328019</ASD_Ligand>
      <Ligand_Name>BIS[5-CHLORO-1H-INDOL-2-YL-CARBONYL-AMINOETHYL]- ETHYLENE GLYCOL $(4S)-2-METHYL-2,4-PENTANEDIOL $1-N-ACETYL-BETA-D-GLUCOSAMINE $PYRIDOXAL-5'-PHOSPHATE</Ligand_Name>
      <PubMed_Title>Human liver glycogen phosphorylase inhibitors bind at a new allosteric site.</PubMed_Title>
      <Author>Rath VL, et al.</Author>
      <Journal>Chem Biol.2000 Sep;7(9):677-82.</Journal>
      <PubMed_ID>10980448</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human glycogen phosphorylase (tense state) in complex with the allosteric inhibitor AVE9423</PDB_Title>
      <PDB_ID>3CEM</PDB_ID>
      <Resolution>2.47</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3CEM</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01320039</ASD_Ligand>
      <Ligand_Name>1-(2-carboxyphenyl)-7-chloro-6-[(2-chloro- 4,6-difluorophenyl)amino]-4-oxo-1,4
-dihydroquinoline- 3-carboxylic acid$1-N-ACETYL-BETA-D-GLUCOSAMINE $PYRIDOXAL-5'-PHOSPHATE</Ligand_Name>
      <PubMed_Title>Thermodynamic characterization of allosteric glycogen phosphorylase inhibitors.</PubMed_Title>
      <Author>Anderka O, et al.</Author>
      <Journal>Biochemistry.2008 Apr 22;47(16):4683-91. Epub  2008 Mar 29.</Journal>
      <PubMed_ID>18373353</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN LIVER GLYCOGEN PHOSPHORYLASE COMPLEXED WITH N-ACETYL-BETA-D-GLUCOPYRANOSYLAMINE</PDB_Title>
      <PDB_ID>1FC0</PDB_ID>
      <Resolution>2.4</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1FC0</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>1-N-ACETYL-BETA-D-GLUCOSAMINE$ PYRIDOXAL-5'-PHOSPHATE</Ligand_Name>
      <PubMed_Title>Activation of human liver glycogen phosphorylase by alteration of the secondary structure and packing of the catalytic core.</PubMed_Title>
      <Author>Rath VL, et al.</Author>
      <Journal>Mol Cell.2000 Jul;6(1):139-48.</Journal>
      <PubMed_ID>10949035</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human Liver Glycogen Phosphorylase A complexed with Chloroindoloyl glycine amide</PDB_Title>
      <PDB_ID>1XOI</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1XOI</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01328015</ASD_Ligand>
      <Ligand_Name>5-CHLORO-1H-INDOLE-2-CARBOXYLIC ACID{[CYCLOPENTYL- (2-HYDROXY-ETHYL)-CARBAMOYL]
-METHYL}-AMIDE $1-N-ACETYL-BETA-D-GLUCOSAMINE $PYRIDOXAL-5'-PHOSPHATE</Ligand_Name>
      <PubMed_Title>5-Chloroindoloyl glycine amide inhibitors of glycogen phosphorylase: synthesis, in vitro, in vivo, and X-ray crystallographic characterization.</PubMed_Title>
      <Author>Wright SW, et al.</Author>
      <Journal>Bioorg Med Chem Lett.2005 Jan 17;15(2):459-65.</Journal>
      <PubMed_ID>15603973</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human liver glycogen phosphorylase complexed with uric acid, N-Acetyl-beta-D-glucopyranosylamine, and CP-403,700</PDB_Title>
      <PDB_ID>1L5S</PDB_ID>
      <Resolution>2.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1L5S</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01320120;ASD01320128</ASD_Ligand>
      <Ligand_Name>[5-CHLORO-1H-INDOL-2-CARBONYL-PHENYLALANINYL]- AZETIDINE-3-CARBOXYLIC ACID $(4R)-2-METHYLPENTANE-2,4-DIOL $1-N-ACETYL-BETA-D-GLUCOSAMINE $PYRIDOXAL-5'-PHOSPHATE $URIC ACID</Ligand_Name>
      <PubMed_Title>Structure-activity analysis of the purine binding  site of human liver glycogen phosphorylase.</PubMed_Title>
      <Author>Ekstrom JL, et al.</Author>
      <Journal>Chem Biol.2002 Aug;9(8):915-24.</Journal>
      <PubMed_ID>12204691</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human liver glycogen phosphorylase (tense state) in complex with the allosteric inhibitor AVE5688</PDB_Title>
      <PDB_ID>3CEH</PDB_ID>
      <Resolution>2.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3CEH</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01320037</ASD_Ligand>
      <Ligand_Name>4-[3-(2-Chloro-4,5-difluoro-benzoyl)ureido]- 3-trifluoromethoxybenzoic acid$2-(N-MORPHOLINO)-ETHANESULFONIC ACID $1-N-ACETYL-BETA-D-GLUCOSAMINE $PYRIDOXAL-5'-PHOSPHATE $PHOSPHATE ION</Ligand_Name>
      <PubMed_Title>Thermodynamic characterization of allosteric glycogen phosphorylase inhibitors.</PubMed_Title>
      <Author>Anderka O, et al.</Author>
      <Journal>Biochemistry.2008 Apr 22;47(16):4683-91. Epub  2008 Mar 29.</Journal>
      <PubMed_ID>18373353</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of glycogen phophorylase complexed with an anthranilimide based inhibitor GSK254</PDB_Title>
      <PDB_ID>3DD1</PDB_ID>
      <Resolution>2.57</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3DD1</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01320136;ASD01320044</ASD_Ligand>
      <Ligand_Name>2-cyclohexyl-N-[(3-{[(2,4,6-trimethylphenyl)carbamoyl]amino}naphthalen- 2
-yl)carbonyl]-D-alanine$CAFFEINE$2-(N-MORPHOLINO)-ETHANESULFONIC ACID $(4S)-2-METHYL-2,4-PENTANEDIOL $1-N-ACETYL-BETA-D-GLUCOSAMINE $ PYRIDOXAL-5'-PHOSPHATE</Ligand_Name>
      <PubMed_Title>Anthranilimide based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. Part 3: X-ray crystallographic characterization, core and urea optimization and in vivo efficacy.</PubMed_Title>
      <Author>Thomson SA, et al.</Author>
      <Journal>Bioorg Med Chem Lett.2009 Feb 15;19(4):1177-82. Epub  2008 Dec 25.</Journal>
      <PubMed_ID>19138846</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human liver glycogen phosphorylase a complexed with glcose and 5-chloro-N-[4-(1,2-dihydroxyethyl)phenyl]-1H-indole-2-carboxamide</PDB_Title>
      <PDB_ID>2ZB2</PDB_ID>
      <Resolution>2.45</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2ZB2</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01320154;ASD01320155</ASD_Ligand>
      <Ligand_Name>5-chloro-N-{4-[(1R)-1,2-dihydroxyethyl]phenyl}- 1H-indole-2-carboxamide $ALPHA-D-GLUCOSE $2-(N-MORPHOLINO)-ETHANESULFONIC ACID $(4S)-2-METHYL-2,4-PENTANEDIOL $PYRIDOXAL-5'-PHOSPHATE</Ligand_Name>
      <PubMed_Title>Synthesis of 5-chloro-N-aryl-1H-indole-2-carboxamide derivatives as inhibitors of human liver glycogen phosphorylase a.</PubMed_Title>
      <Author>Onda K, et al.</Author>
      <Journal>Bioorg Med Chem.2008 May 15;16(10):5452-64. Epub  2008 Apr 11.</Journal>
      <PubMed_ID>18434170</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human liver glycogen phosphorylase- GL complex</PDB_Title>
      <PDB_ID>2QLL</PDB_ID>
      <Resolution>2.56</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2QLL</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>PYRIDOXAL-5'-PHOSPHATE</Ligand_Name>
      <PubMed_Title>Molecular recognition of the protein phosphatase 1 glycogen targeting subunit by glycogen phosphorylase.</PubMed_Title>
      <Author>Pautsch A, et al.</Author>
      <Journal>J Biol Chem.2008 Apr 4;283(14):8913-8. Epub  2008 Jan 15.</Journal>
      <PubMed_ID>18198182</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of glycogen phosphorylase complexed with an anthranilimide based inhibitor GSK261</PDB_Title>
      <PDB_ID>3DDS</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3DDS</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01320118;ASD01320044</ASD_Ligand>
      <Ligand_Name>O-tert-butyl-N-[(3-{[(2,4,6-trimethylphenyl)carbamoyl]amino}naphthalen- 2
-yl)carbonyl]-L-threonine$CAFFEINE $2-(N-MORPHOLINO)-ETHANESULFONIC ACID $(4S)-2-METHYL-2,4-PENTANEDIOL $1-N-ACETYL-BETA-D-GLUCOSAMINE $PYRIDOXAL-5'-PHOSPHATE $PHOSPHATE ION</Ligand_Name>
      <PubMed_Title>Anthranilimide based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. Part 3: X-ray crystallographic characterization, core and urea optimization and in vivo efficacy.</PubMed_Title>
      <Author>Thomson SA, et al.</Author>
      <Journal>Bioorg Med Chem Lett.2009 Feb 15;19(4):1177-82. Epub  2008 Dec 25.</Journal>
      <PubMed_ID>19138846</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of glycogen phosphorylase complexed with an anthranilimide based inhibitor GSK055</PDB_Title>
      <PDB_ID>3DDW</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3DDW</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01320138;ASD01320044</ASD_Ligand>
      <Ligand_Name>(2S)-{[(3-{[(2-chloro-6-methylphenyl)carbamoyl]amino}naphthalen- 2
-yl)carbonyl]amino}(phenyl)ethanoic acid $CAFFEINE $2-(N-MORPHOLINO)-ETHANESULFONIC ACID $(4S)-2-METHYL-2,4-PENTANEDIOL $1-N-ACETYL-BETA-D-GLUCOSAMINE$PYRIDOXAL-5'-PHOSPHATE</Ligand_Name>
      <PubMed_Title>Anthranilimide based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. Part 3: X-ray crystallographic characterization, core and urea optimization and in vivo efficacy.</PubMed_Title>
      <Author>Thomson SA, et al.</Author>
      <Journal>Bioorg Med Chem Lett.2009 Feb 15;19(4):1177-82. Epub  2008 Dec 25.</Journal>
      <PubMed_ID>19138846</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Glycogen Phosphorylase Inhibitors</PDB_Title>
      <PDB_ID>2ATI</PDB_ID>
      <Resolution>1.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2ATI</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01328020</ASD_Ligand>
      <Ligand_Name>ALPHA-D-GLUCOSE$ N-(2-CHLORO-4-FLUOROBENZOYL)-N'-(5-HYDROXY- 2-METHOXYPHENYL)UREA $PYRIDOXAL-5'-PHOSPHATE</Ligand_Name>
      <PubMed_Title>Acyl ureas as human liver glycogen phosphorylase inhibitors for the treatment of type 2 diabetes.</PubMed_Title>
      <Author>Klabunde T, et al.</Author>
      <Journal>J Med Chem.2005 Oct 6;48(20):6178-93.</Journal>
      <PubMed_ID>16190745</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human glycogen phosphorylase (tense state) in complex with the allosteric inhibitor AVE2865</PDB_Title>
      <PDB_ID>3CEJ</PDB_ID>
      <Resolution>3.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3CEJ</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD01320134</ASD_Ligand>
      <Ligand_Name>1-{2-[3-(2-Chloro-4,5-difluoro-benzoyl)-ureido]- 4-fluoro-phenyl}-piperidine-4
-carboxylic acid$1-N-ACETYL-BETA-D-GLUCOSAMINE$PYRIDOXAL-5'-PHOSPHATE</Ligand_Name>
      <PubMed_Title>Thermodynamic characterization of allosteric glycogen phosphorylase inhibitors.</PubMed_Title>
      <Author>Anderka O, et al.</Author>
      <Journal>Biochemistry.2008 Apr 22;47(16):4683-91. Epub  2008 Mar 29.</Journal>
      <PubMed_ID>18373353</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko00500</Pathway_ID>
      <Pathway_Title>Starch and sucrose metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Carbohydrate metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04922</Pathway_ID>
      <Pathway_Title>Glucagon signaling pathway</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Endocrine system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04910</Pathway_ID>
      <Pathway_Title>Insulin signaling pathway</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Endocrine system</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <SCOP_Class>Alpha and beta proteins (a/b)</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.d.bch.b.h.b.html</SCOP_URL>
    <CATH_Class>Mixed alpha-beta</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/1em6</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Detail>site,310,Arg;site,311,Arg;site,76,Tyr;site,43,Asp</Site_Detail>
      <Site_Reference>Rath VL, et al. Mol.Cell. 2000,6(1):139-148.</Site_Reference>
      <Site_Type>Oligomerization</Site_Type>
      <PDB_ID>1FA9;1L5Q;1L7X;3CEH;3CEJ;3CEM;3DD1;3DDS;3DDW</PDB_ID>
      <PubMed_ID>10949035</PubMed_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>2.4.1.1</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC2/4/1/1.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD00030001</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00150001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00360002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00390001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00870006</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01240004</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320003</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320004</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320005</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320006</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320007</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320008</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320009</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320010</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320011</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320012</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320013</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320014</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320015</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320016</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320017</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320018</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320019</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320020</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320021</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320022</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320023</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320024</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320026</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320030</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320031</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320032</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320033</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320034</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320035</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320036</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320037</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320039</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320040</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320041</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320043</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320044</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320045</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320046</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320047</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320048</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320050</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320051</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320052</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320053</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320054</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320055</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320056</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320057</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320058</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320059</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320060</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320061</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320062</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320063</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320064</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320065</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320066</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320067</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320068</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320070</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320071</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320072</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320073</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320074</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320075</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320076</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320079</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320080</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320090</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320091</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320092</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320095</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320096</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320097</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320103</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320112</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320114</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320115</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320116</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320118</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320120</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320121</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320124</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320128</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320134</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320136</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320138</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320145</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320146</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320147</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320148</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320149</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320151</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320152</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320154</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320155</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320158</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320159</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320160</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320161</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01320162</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01328001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01328002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01328003</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01328004</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01328005</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01328006</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01328008</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01328009</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01328010</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01328011</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01328012</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01328013</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01328014</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01328015</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01328019</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01328020</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01328021</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01328022</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01328023</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01328024</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01328025</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01328026</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01328027</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01328028</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01328029</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01328032</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01328033</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01328034</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01328035</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01328036</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD02820003</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-05-31</Create_Date>
</Organism_Record>